ZT-01: A novel somatostatin receptor 2 antagonist for restoring the glucagon response to hypoglycaemia in type 1 diabetes.
Rawad FarhatJulian AikenNinoschka C D'SouzaDaniel AppaduraiGrayson HullEric SimonsonRichard T LigginsMichael C RiddellOwen ChanPublished in: Diabetes, obesity & metabolism (2022)
We conclude that ZT-01 may be effective in restoring glucagon responses and preventing the onset of hypoglycaemia in patients with T1D.